Discontinued — last reported Q3 '23
Eli Lilly Derivative assets decreased by 0.2% to $6.02B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.7%, from $5.75B to $6.02B. Over 4 years (FY 2020 to FY 2024), Derivative assets shows an upward trend with a 4.4% CAGR.
Fluctuations reflect changes in market conditions and the firm's overall derivative hedging or trading strategy.
This represents the fair value of derivative contracts that are in a gain position for the firm. These instruments are u...
Standard for large financial institutions with significant capital markets operations.
fin_derivative_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.36B | $5.95B | $5.79B | $4.90B | $5.38B | $4.94B | $5.45B | $5.58B | $5.57B | $5.38B | $5.67B | $5.54B | $5.50B | $5.75B | $5.34B | $5.54B | $6.03B | $6.02B |
| QoQ Change | — | +36.5% | -2.7% | -15.4% | +9.8% | -8.2% | +10.3% | +2.4% | -0.2% | -3.4% | +5.4% | -2.3% | -0.7% | +4.5% | -7.1% | +3.7% | +8.8% | -0.2% |
| YoY Change | — | — | — | — | +23.4% | -17.0% | -5.9% | +13.9% | +3.5% | +8.9% | +4.0% | -0.7% | -1.3% | +6.9% | -5.8% | +0.0% | +9.6% | +4.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.